Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.

作者: Barbara E. Ostrov

DOI: 10.3109/08820139.2015.1093912

关键词:

摘要: In recent decades, innovative strategies to treat patients with inflammatory, immunologically based diseases have advanced in concert our increased understanding of molecular immunology. Recognition the spectrum and pathophysiology autoimmune autoinflammatory disorders has allowed for development cutting-edge therapies such patients. this review, key immunotherapeutic approaches treating inflammatory disorders, as rheumatoid arthritis (RA) systemic lupus erythematosus (SLE), well genetic diseases, cryopyrin associated periodic syndromes, are addressed. Indications, risks additional considerations use these agents reviewed.

参考文章(77)
Matthew J Brookes, Jonathon R B Green, Maintenance of Remission in Crohn’s Disease Drugs. ,vol. 64, pp. 1069- 1089 ,(2004) , 10.2165/00003495-200464100-00004
Jessica Burch, PharmD, Bcps, Mary Onysko, PharmD, Bcps, Current standards and future treatments of rheumatoid arthritis Formulary. ,(2012)
M A Dicato, C Duhem, F Ries, Side-effects of intravenous immune globulins. Clinical and Experimental Immunology. ,vol. 97, pp. 79- 83 ,(1994)
Fabio Martinon, Kimberly Burns, Jürg Tschopp, The Inflammasome Molecular Cell. ,vol. 10, pp. 417- 426 ,(2002) , 10.1016/S1097-2765(02)00599-3
Silvio Danese, Miquel Sans, Franco Scaldaferri, Alessandro Sgambato, Sergio Rutella, Achille Cittadini, Josep M. Piqué, Julian Panes, Jeffry A. Katz, Antonio Gasbarrini, Claudio Fiocchi, TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease Journal of Immunology. ,vol. 176, pp. 2617- 2624 ,(2006) , 10.4049/JIMMUNOL.176.4.2617
Richmal M Oates-Whitehead, J Harry Baumer, Linda Haines, Samantha Love, Ian K Maconochie, Amit Gupta, Kevin Roman, Jaspal S Dua, Ichiko Flynn, Intravenous immunoglobulin for the treatment of Kawasaki disease in children Cochrane Database of Systematic Reviews. ,vol. 2003, ,(2003) , 10.1002/14651858.CD004000
Jasvinder A Singh, Chris Cameron, Shahrzad Noorbaloochi, Tyler Cullis, Matthew Tucker, Robin Christensen, Elizabeth Tanjong Ghogomu, Doug Coyle, Tammy Clifford, Peter Tugwell, George A Wells, Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis The Lancet. ,vol. 386, pp. 258- 265 ,(2015) , 10.1016/S0140-6736(14)61704-9
Megan KL MacLeod, Stephen M Anderton, Antigen-based immunotherapy (AIT) for autoimmune and allergic disease Current Opinion in Pharmacology. ,vol. 23, pp. 11- 16 ,(2015) , 10.1016/J.COPH.2015.05.003
Larry J Kricka, Human Anti-Animal Antibody Interferences in Immunological Assays Clinical Chemistry. ,vol. 45, pp. 942- 956 ,(1999) , 10.1093/CLINCHEM/45.7.942
Marco Gattorno, Alberto Martini, Treatment of autoinflammatory syndromes. Current Opinion in Pediatrics. ,vol. 22, pp. 771- 778 ,(2010) , 10.1097/MOP.0B013E3283404598